ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BIOM Biomira Inc. - Common Shares (MM)

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Biomira Inc. - Common Shares (MM) NASDAQ:BIOM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Biomira Inc - Report of Foreign Issuer (6-K)

31/10/2007 3:03pm

Edgar (US Regulatory)


 


 
FORM 6-K
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 

Dated October 31, 2007
 
BIOMIRA INC.    

(Translation of registrant’s name into English)
 
Edmonton Research Park
2011-94 Street, Edmonton, Alberta Canada T6N1H1  

(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
 
Form 20-F x
(for past years ending in calendar year 1996)
Form 40-F x
(commencing in calendar year 1997)
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes o
No x
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):                    
 


 


EXPLANATORY NOTE
 
On October 30, 2007, Biomira Inc. (“Biomira”) filed with the System for Electronic Document Analysis and Retrieval in Canada (“SEDAR”) a News Release related to the announcement that Robert Kirkman, M.D., Biomira’s President and Chief Executive Officer, is scheduled to present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference.  A copy of the News Release is attached to this report as Exhibit 1.




EXHIBIT INDEX

Exhibit Number
 
Description of Document
     
1
 
News Release (incorporated by reference from Biomira’s Rule 425 submission filed with the Securities and Exchange Commission on October 30, 2007).

 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
BIOMIRA INC.
 
(Registrant) 
 
 
 
 
Date: October 31, 2007
By:
/s/ Edward A. Taylor 
 
 
Edward A. Taylor 
 
 
Vice President, Finance & Administration and Chief Financial Officer
 
 
 

1 Year Biomira Inc. - Common Shares (MM) Chart

1 Year Biomira Inc. - Common Shares (MM) Chart

1 Month Biomira Inc. - Common Shares (MM) Chart

1 Month Biomira Inc. - Common Shares (MM) Chart

Your Recent History

Delayed Upgrade Clock